New Hampshire SB606 mandates coverage for biomarker testing under Medicaid when deemed medically necessary.
New Hampshire SB606 amends the state Medicaid plan to require coverage for biomarker testing when determined medically necessary by the New Hampshire Medicaid program. This coverage applies to diagnosis, treatment, management, or monitoring of a beneficiary's disease or condition. The bill defines "biomarker" and "biomarker testing" and mandates that risk-bearing entities contracted under the state Medicaid plan provide biomarker testing at the same scope, duration, and frequency as the Medicaid program provides to enrollees.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.